Debio-0328

N/A

Report date: 2025/11/20 11:38:30

Base Information

Drug NameDebio-0328
Drug Alias Name[68Ga]Ga-DPI-4452Gallium-68-DPI-4452ITM-94D68Ga-DPI-4452
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionAnti-Carbonic anhydrase IXIonising radiation emitters
TargetsCarbonic anhydrase IX
Therapy Area/IndicationsUrinary Bladder NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesITM Oncologics GmbH
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A